Nanfang Hospital Southern Medical University | ClinicalTrials HQ

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease	Angina Pectoris, Arterial Occlusive Diseases, Chest Pain, Infarction, Necrosis, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, intermediate coronary syndrome, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder	Active, not recruiting	Not stated	2026-09-04		NCT06295679
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-08-18		NCT06656494
A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China	glucocorticoid-induced osteoporosis	Active, not recruiting	Phase 4	2026-05-27		NCT06588153
Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Active, not recruiting	Phase 2 / Phase 3	2026-04-01		NCT05203679
A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia	β -Thalassemia	Recruiting	Phase 2	2026-02-27		NCT06302491
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China	Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis	Active, not recruiting	Phase 4	2026-02-12		NCT06332014
To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Recruiting	Phase 3	2025-12-09		NCT06833983
Interventional Left Ventricular Assist System for PCI in CHIP Patients	High-Risk Percutaneous Coronary Intervention (High-risk PCI); Left Ventricular Assist Devices	Recruiting	Not applicable	2025-08-26		NCT07053618